Skip to content

Tegoprazan

DRUG19 trials

Sponsors

HK inno.N Corporation, Incheon St.Mary's Hospital, Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., Yanqing Li, Pusan National University Hospital

Conditions

Adverse ReactionErosive Reflux DiseaseGastroesophageal Reflux DiseaseGeneral AnesthesiaHealthyHealthy Male VolunteersHealthy VolunteerHelicobacter Pylori Eradication

Phase 1

Phase 2

Phase 3

Phase 4

Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance
CompletedNCT04309916
HK inno.N CorporationErosive Reflux Disease
Start: 2020-05-22End: 2021-11-30Updated: 2022-02-25
A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn
NCT05701540
HK inno.N CorporationGastroesophageal Reflux Disease
Start: 2023-03-24End: 2024-12-31Target: 338Updated: 2023-08-03
Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole
Not yet recruitingNCT06318104
Hospital General de México Dr. Eduardo LiceagaHelicobacter Pylori Infection
Start: 2024-04-19End: 2025-02-28Target: 160Updated: 2024-03-19
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
Active, not recruitingNCT06523764
Xijing Hospital of Digestive DiseasesHelicobacter Pylori Infection Chronic Gastrit
Start: 2024-11-11End: 2025-10-01Target: 208Updated: 2025-07-03
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
Enrolling by invitationNCT06743243
Seok Kyeong OhGeneral Anesthesia
Start: 2025-07-23End: 2026-12-30Target: 174Updated: 2025-09-05
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
RecruitingNCT06991348
Carnot LaboratoriesGastroesophageal Reflux Disease
Start: 2024-07-30End: 2025-11-30Target: 128Updated: 2025-07-23

Unknown Phase

Related Papers